The size of the vaccine market will reach USD 73.78 billion in 2028;

New York, June 02, 2021 (GLOBE NEWSWIRE) – Market size – $ 42 billion in 2020 Market growth – 7.3% Market trends – Expansion of the pharmaceutical industry and desire to vaccinate everything

The global vaccine market size is expected to reach $ 73.78 billion in 2028, registering a CAGR of 7.3% over the forecast period, according to the latest report from Reports and Data. The major factors driving the market revenue growth are the increasing prevalence of infectious diseases, increasing public funding for vaccine production, and increasing emphasis on vaccination.

Immunization is a global health and growth success story, saving millions of lives every year. Vaccines minimize the risk of a human body contracting disease by strengthening its natural defenses. More than 20 deadly diseases can now be prevented with vaccination, enabling people of all ages to live longer and healthier lives. Each year, vaccines prevent 2-3 million deaths from diseases such as diphtheria, tetanus, whooping cough, influenza and measles.

Request a free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/4023

Increased efforts to immunize all children and all adults would stimulate the growth of the vaccine market. Immunization is an indisputable human right and an essential component of primary health care. Over a billion children have been immunized over the past decade. Vaccines are also essential for preventing and controlling outbreaks of infectious diseases. They help fight antimicrobial resistance and underpin global health security. The Global Vaccine Action Plan (GVAP), which was endorsed by the 194 member states of the World Health Assembly in May 2012, is a mechanism to prevent millions of deaths by 2020 by providing equal access to current vaccines to people from all walks of life. .

The coronavirus infection has recently infected millions of people around the world. In some areas, community transmission has led to an increase in the number of victims. Biopharmaceutical and biotechnology companies have successfully brought to market an effective vaccine against the virus that causes SARS-Cov-2 in 2021. The COVID-19 pandemic has generated unprecedented demand and companies are investing heavily in the activities of R&D with governments around the world to meet growing demand. request for vaccines. The growth prospects of the market will be enhanced by the expansion of manufacturing facilities to meet growing demand.

Despite significant progress, a variety of people around the world still do not have access to vaccines, including nearly 20 million babies per year. Progress has slowed or even reversed in some countries, and there is a real danger that appeasement will undo previous achievements. In addition, the high costs of storing and transporting vaccines can stifle market supply to some extent. These factors are expected to hamper the market revenue growth to some extent during the forecast period.

To identify key industry trends, click on the link below: https://www.reportsanddata.com/report-detail/vaccines-market

Some highlights of the report:

  • The conjugate vaccine segment held the largest share of the vaccine market in 2020. The increase in public funding and the growing investments by companies in the production of conjugate vaccines may be due to the large share of this segment.
  • Due to growing concerns for vaccination against a number of predominant infectious diseases, which are the leading causes of mortality and morbidity, most disease indication segments have experienced considerable growth.
  • The intramuscular and subcutaneous administration segment accounted for the largest share of the vaccine market revenue in 2020.
  • The pediatric patient segment accounted for the largest revenue share among other patient type segments in 2020.
  • In 2020, North America held the largest share of the vaccine industry. North America’s substantial share of the global vaccine market can be attributed to increased public awareness of the risks of infectious diseases, as well as increased government and non-government spending on production and widespread distribution. vaccines.
  • The fastest growth is expected in the Asia-Pacific region during the forecast period, due to a growing target population with high unmet clinical needs.

The major players in the global vaccine market are:

  • GlaxoSmithKline plc
  • Pfizer, Inc
  • Merck & Co., Inc.
  • Sanofi Pasteur
  • CSL Limited
  • Emergent BioSolutions, Inc.
  • Johnson & johnson
  • Serum Institute of India
  • AstraZeneca
  • Bavarian Nordic
  • Mitsubishi Tanabe Pharma Corporation
  • Daiichi Sankyo Company, Limited.

Order now: https://www.reportsanddata.com/checkout-form/4023

Segments covered in the report

For the purpose of this study, Reports and Data segmented the global vaccine market on the basis of technology, type, disease indication, route of administration, patient type, and region:
Technology Outlook (Revenue, Billions USD, 2018 – 2028)

    • Conjugate vaccines
    • Inactivated and subunit vaccines
    • Live attenuated vaccines
    • Recombinant vaccines
    • Toxoid vaccines

Type Outlook (Revenue, Billions USD, 2018 – 2028)

    • Monovalent vaccines
    • Multivalent vaccines

Indication of disease Outlook (Revenue, Billions USD, 2018 – 2028)

    • Pneumococcal disease
    • DTP
    • Influenza
    • HPV
    • Meningococcal disease
    • Polio
    • Rotavirus
    • Hepatitis
    • MMR
    • Varicella
    • Shingles
    • Other indications of illness

Route of administration Outlook (Revenue, Billions USD, 2018 – 2028)

    • Intramuscular and subcutaneous administration
    • Oral administration
    • Other routes of administration

Patient type Outlook (Revenue, Billions USD, 2018 – 2028)

    • Pediatric patients
    • Adult patients

Regional outlook (revenue, billion USD, 2018 – 2028)

    • North America
    • Europe
      • Germany
      • Great Britain
      • France
      • Italy
      • Spain
      • The rest of europe
    • Asia Pacific
      • China
      • Japan
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • AEM
      • South Africa
      • Saudi Arabia
      • Rest of the MEA

Browse similar research reports:

Market size of humanized mouse models, Sharing and analysis, by type (genetic, cellular), by application (neuroscience, hematopoiesis, oncology, toxicology, infectious diseases and others), by end use (pharmaceutical and biotechnology companies, CROs, academic and research institutes), and by region, forecast until 2028

Microbial and Bacterial Cellulose Production Market Size, Share and analysis, by growth medium (synthetic media), by production method (static method), by type of bacteria (Gram-negative bacteria), by application (pharmaceutical and medical applications), forecast until 2028

Animal Growth Promoters and Performance Enhancers Market Size, Sharing and analysis, by type (antibiotic growth promoters, non-antibiotic growth promoters), by animal type (poultry, pig, livestock, aquaculture, others), by region, forecast to 2028

Depth filtration market size, Sharing and analysis, by media type (cellulose, activated carbon, diatomaceous earth), by product (cartridge, capsule, sheet, modulus, others), by end use (healthcare, food and beverage, filtration of water, other) and By region, forecast until 2028

About reports and data
Reports and Data is a market research and consulting company that provides syndicated research reports, custom research reports, and consulting services. Our solutions focus uniquely on your goal to locate, target and analyze changes in consumer behavior across demographics, across industries and help customers make smarter business decisions. We offer market intelligence studies ensuring relevant and factual research across many industries including healthcare, technology, chemicals, power and energy. We are constantly updating our research offerings to ensure that our clients are up to date with the latest trends that exist in the market. Reports and Data has a solid base of experienced analysts from various fields of expertise.

Contact us:
John W
Head of Business Development
Reports and Data | The Web: www.reportsanddata.com
Direct line: + 1-212-710-1370
E-mail: [email protected]
Read the full press release: https://www.reportsanddata.com/press-release/global-vaccines-market


Source link

About Mike Stevenson

Check Also

Farmers’ Federation supports Kenneth Paschal for House District 73

The Alabama Farmers Federation announced Tuesday that it is approving Kenneth Paschal for the Alabama …